Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.
Paul MR, Pan TC, Pant DK, Shih NN, Chen Y, Harvey KL, Solomon A, Lieberman D, Morrissette JJ, Soucier-Ernst D, Goodman NG, Stavropoulos SW, Maxwell KN, Clark C, Belka GK, Feldman M, DeMichele A, Chodosh LA. Paul MR, et al. Among authors: maxwell kn. J Clin Invest. 2020 Aug 3;130(8):4252-4265. doi: 10.1172/JCI129941. J Clin Invest. 2020. PMID: 32657779 Free PMC article.
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A. Maxwell KN, et al. Breast Cancer Res Treat. 2017 Aug;164(3):627-638. doi: 10.1007/s10549-017-4257-x. Epub 2017 May 12. Breast Cancer Res Treat. 2017. PMID: 28500398 Free PMC article.
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A. Maxwell KN, et al. Breast Cancer Res Treat. 2017 Aug;164(3):639-640. doi: 10.1007/s10549-017-4339-9. Breast Cancer Res Treat. 2017. PMID: 28653249 No abstract available.
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, Daber R, Morrissette JJD, Mitra N, Feldman M, Domchek SM, Nathanson KL. Maxwell KN, et al. Nat Commun. 2017 Aug 22;8(1):319. doi: 10.1038/s41467-017-00388-9. Nat Commun. 2017. PMID: 28831036 Free PMC article.
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.
Kraya AA, Maxwell KN, Wubbenhorst B, Wenz BM, Pluta J, Rech AJ, Dorfman LM, Lunceford N, Barrett A, Mitra N, Morrissette JJD, Feldman M, Nayak A, Domchek SM, Vonderheide RH, Nathanson KL. Kraya AA, et al. Among authors: maxwell kn. Clin Cancer Res. 2019 Jul 15;25(14):4363-4374. doi: 10.1158/1078-0432.CCR-18-0468. Epub 2019 Mar 26. Clin Cancer Res. 2019. PMID: 30914433 Free PMC article.
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients.
Sun L, Surya S, Le AN, Desai H, Doucette A, Gabriel P, Ritchie M, Rader D, Maillard I, Bange E, Huang A, Vonderheide RH, DeMichele A, Verma A, Mamtani R, Maxwell KN. Sun L, et al. Among authors: maxwell kn. medRxiv [Preprint]. 2020 Aug 15:2020.08.14.20174961. doi: 10.1101/2020.08.14.20174961. medRxiv. 2020. PMID: 32817956 Free PMC article. Updated. Preprint.
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers.
Maxwell KN, Wenz BM, Kulkarni A, Wubbenhorst B, D'Andrea K, Weathers B, Goodman N, Vijai J, Lilyquist J, Hart SN, Slavin TP, Schrader KA, Ravichandran V, Thomas T, Hu C, Robson ME, Peterlongo P, Bonanni B, Ford JM, Garber JE, Neuhausen SL, Shah PD, Bradbury AR, DeMichele AM, Offit K, Weitzel JN, Couch FJ, Domchek SM, Nathanson KL. Maxwell KN, et al. JCO Precis Oncol. 2020 Aug 19;4:PO.19.00301. doi: 10.1200/PO.19.00301. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32954205 Free PMC article.
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients.
Sun L, Surya S, Le AN, Desai H, Doucette A, Gabriel P, Ritchie MD, Rader D, Maillard I, Bange E, Huang AC, Vonderheide RH, DeMichele A, Verma A, Mamtani R, Maxwell KN. Sun L, et al. Among authors: maxwell kn. JNCI Cancer Spectr. 2021 Jan 21;5(1):Pkaa120. doi: 10.1093/jncics/pkaa120. eCollection 2021 Feb. JNCI Cancer Spectr. 2021. PMID: 33554040 Free PMC article.
105 results